Treating Chronic Refractory Osteomyelitis Adjuctive With HBOT
Do you have patients who are suffering from chronic refractory osteomyelitis?
If so, you’re not alone. There are over 50,000 hospital admissions of patients with chronic refractory osteomyelitis every year.
But what are your treatment options?
We’ll discuss those options in this post. But first, let’s consider the disease and some common etiologies.
What exactly is chronic refractory osteomyelitis?
We went to the healthcare professionals at the Mayo Clinic for some guidance:
chronic refractory osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Infections can also begin in the bone itself if an injury exposes the bone to germs.
Smokers and people with chronic health conditions, such as diabetes or kidney failure, are more at risk of developing chronic refractory osteomyelitis. People who have diabetes may develop chronic refractory osteomyelitis in their feet if they have foot ulcers.
As an infection that’s often carried in the blood or transferred from infected tissue, chronic refractory osteomyelitis is often treated with antibiotics, physical procedures, and surgery.
In the most extreme cases, including chronic refractory osteomyelitis (CRO), amputation may need to be considered.
Common causes of the disease include traumatic bodily injuries, deep puncture wounds, and surgeries. As the Mayo Clinic also points out, patients struggling with PAD and diabetic foot wounds can be in a position of elevated risk.
So, are there additional effective treatment options for patients with chronic refractory osteomyelitis?
Yes, and Hyperbaric Oxygen Therapy, as part of a comprehensive treatment regimen, and is an important adjunctive therapy to be considered.
HBOT is administered in a pressurized chamber that allows the patient to breathe pure oxygen at pressures higher than atmospheric pressure. This results in increased oxygen in the bloodstream and increased oxygen dissolved in plasma.
How do HBOT treatments have a positive effect on patients struggling with chronic refractory osteomyelitis?
Here are just some of the benefits as outlined by the HBOT experts at Hyperbaric Aware:
- Improved Penetration Of Specific Antibiotics Used To Treat chronic refractory osteomyelitis
- Stimulates Osteogenesis And Angiogenesis
- Increased Bone Oxygen Content
- Prevents Specific White Blood Cells From Adhering To Damaged Blood Vessel Linings
- Can Prevent Significant New Bacterial Growth
HBOT might just be the adjunct therapy you’re looking for to treat patients struggling with chronic refractory osteomyelitis.
Hyperbaric oxygen therapy can be extremely efficacious as part of a comprehensive treatment plan.
And, as always, early diagnosis and consideration of the full spectrum of treatment options can be game-changing for your patients.
Would you like to learn more about HBOT treatment solutions from a dedicated team of experts? At CūtisCare, our delivery models are designed to fill a critical void for professionals in the wound care diagnosis, treatment, and healing space.
We’re a healing-centric, compliance-driven organization focused on providing innovative, effective, purpose-built clinical solutions for chronic wound care and treatment.
Our solutions are always designed to augment the staffing and clinical strengths of our diverse group of partners.
Could your hospital, practice, or clinic benefit from improved wound care treatment capabilities, including the treatment of chronic refractory osteomyelitis?